2018 CORPORATE MEMBER PROSPECTUS

CRA SUSTAINS ADVOCACY FOCUS

R

R

R

R

R

R

R

R

CRA was instrumental in achieving legislative victories on 2017 priority issues, including: } Ensuring copayment assistance for biologics and biosimilars remained accessible to patients } Stalled legislation that would have hindered educational opportunities for physicians through a meal and gift ban.

CRA provided extensive issues support in 2017 through membership, Calls to Action, CRA Position Letters, and On-Site Advocacy

CRA supported federal efforts on physician reimbursement, medication access and network adequacy } Visits to Washington DC from CRA leadership addressing priority issues } CRA signed & co-signed letters on federal legislative and regulatory issues } Federal comments on physician reimbursement

CRA provides advocacy engagement and issuesawareness online through social media including Twitter @calrheum

CRA keeps members up-to-date with the latest news impacting the rheumatic community through legislative newsletters, e-blasts, and theCRA website

CRA prepares members with advocacy and legislative committee testimony training

CRA offers educational resources and advocacylegislative committee testimony training } CRA Annual Meeting } Webinars } Member Advocacy Day in Sacramento

CRA offers a growing number of advocacy resources on our website for our members, patients, and the public

On Twitter: @CalRheum

CRA GROWS IMPACT & PARTNERSHIPS

R

R

R

R

This year, CRA engaged at both the local and state level on behalf of its members when Independent Physician Associations began pressuring rheumatologists to make changes to their patients’ medications. In addition to corresponding directly with one southernCalifornia-based IPA, the CRA met with stateregulators at the Department of Managed HealthCare to raise concerns. We will continue working on issues rheumatologists face whether legislatively or regulatorily.

Collaboration helps augment CRA’s effectiveness. CRA works with groups and partners such as: } Coalition of State Rheumatology Organizations } Arthritis Foundation } American College of Rheumatology } Other disease-specific patient groups such as the National Psoriasis Foundation } California Medical Association

CRA continued to participate in the Joint Advocacy Day with the California Arthritis Foundation and the National Psoriasis Foundation in Sacramento on May 8, 2017.

CRA also participates in a number of issue-basedcoalitions including the California Chronic Care Coalition and Californians Allied for Patient Protection.

CRA LOOKS INTO IPAs

COLLABORATION

l Membership in CRA Industry Council, including 4 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl Named sponsor of Board of Directors meal and/or general attendees meal in conjunction with the Annual Meeting (sponsor to cover all costs associated with the meal)l First right of refusal for the Board Dinner sponsorship at the Annual Meetingl Named sponsorship of meal in conjunction with Advocacy Day program (sponsor to cover costs associated with meal)l Meeting between the CRA Advocacy Committee and sponsor representative at the VP level or above in conjunction with the ACR Annual Meeting in the Fall. l Meeting with select CRA Board Members in the Falll Quarterly conference calls or in-person meetings with CRA President to discuss clinical and/ or advocacy issues affecting California rheumatologyl Monthly conference calls or in-person meetings with CRA Executive Director to discuss educational, legislative, or regulatory, and/or payer relations issues impacting California rheumatologyl Partner with CRA on common interest legislative, regulatory or medical policy issues. l Sponsorship of 2 webinars a year on a mutual legislative, regulatory or educational priority of which CRA will promote to its membership (Board approval of topic necessary. Sponsor to cover all costs of the webinar). l New company announcements (up to 6 a year) on CRA’s website in “External News” and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support on CRA website homepage as well as recognition on “Our Partners” page with link to sponsor’s homepagel Acknowledgement of corporate support in member e-newsletters with logo and link to homepagel Access to members’ only section of CRA website (1 account, which must be identified by the sponsor), including membership directory and online message board areas. l Sponsorship recognized at the Annual Board Meetingl Complimentary copy (up to 5) of Annual Meeting Syllabusl Logo acknowledgement of support included on publication distributed at Annual Meeting

DIAMOND LEVEL $50,000

l Membership in CRA Industry Council, including 2 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl Named sponsor of Board of Directors meal and/or general attendees meal in conjunction with the Annual Meeting (sponsor to cover all costs associated with the meal)l Meeting with select CRA Advocacy Committee at the Annual Meetingl Meeting between the CRA Advocacy Committee and sponsor representative at the VP level or above in conjunction with the ACR Annual Meeting in the Fall. l Bi-annual conference calls or in-person meetings with CRA President to discuss clinical and/ or advocacy issues affecting California rheumatologyl Quarterly conference calls or in-person meetings with CRA Executive Director to discuss educational, legislative, or regulatory, and/or payer relations issues impacting California rheumatologyl Partner with CRA on common interest legislative, regulatory or medical policy issuesl New company announcements (up to 4 a year) on CRA’s website in “External News” and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support on CRA website homepage as well as recognition on “Our Partners” page with link to sponsor’s homepagel Acknowledgement of corporate support in member e-newsletters with logo and link to homepagel Access to members’ only section of CRA website (1 account, which must be identified by the sponsor), including membership directory and online message board areas. l Sponsorship recognized at the Annual Board Meetingl Complimentary copy (up to 5) of Annual Meeting Syllabusl Logo acknowledgement of support included on publication distributed at Annual Meeting

PLATINUM LEVEL $30,000

l Membership in CRA Industry Council, including 2 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl Meeting between the CRA Advocacy Committee and sponsor representative at the VP level or above in conjunction with the ACR Annual Meeting in the Fall. l Annual conference calls or in-person meetings with CRA President to discuss clinical and/ or advocacy issues affecting California rheumatologyl Quarterly conference calls or in-person meetings with CRA Executive Director to discuss educational, legislative, or regulatory, and/or payer relations issues impacting California rheumatologyl Partner with CRA on common interest legislative, regulatory or medical policy issuesl New company announcements (up to 2 a year) on CRA’s website in “External News” and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support on CRA website homepage as well as recognition on “Our Partners” page with link to sponsor’s homepagel Acknowledgement of corporate support in member e-newslettersl Sponsorship recognized at the Annual Board Meetingl Complimentary copy (up to 3) of Annual Meeting Syllabusl Logo acknowledgement of support included on publication distributed at Annual Meeting

GOLD LEVEL $20,000

l Membership in CRA Industry Council, including 1 attendees to the Industry Roundtable meeting between CRA Board of Directors and Council at the Annual Meetingl Partner with CRA on common interest legislative, regulatory or medical policy issuesl New company announcements (up to 2 a year) on CRA’s website in “External News” and broadcast on CRA’s social media accounts, including Twitter and Facebookl Acknowledgement of corporate support in member e-newslettersl Acknowledgement of corporate support on CRA website on “Our Partners” webpage with link to sponsor’s homepagel Sponsorship recognized at the Annual Board Meetingl Complimentary copy (up to 2) of Annual Meeting Syllabusl Logo acknowledgement of support included on publication distributed at Annual Meeting

l Acknowledgement of corporate support on CRA website on “Our Partners” webpage with link to sponsor’s homepagel Sponsorship recognized at the Annual Board Meetingl Complimentary copy (up to 2) of Annual Meeting Syllabusl Logo acknowledgement of support included on publication distributed at Annual Meeting

SILVER LEVEL

BRONZE LEVEL

$10,000

$5,000

“Advocacy for Patient Access to Rheumatology Care”MISSION STATEMENT

FOR MORE INFORMATION

Shanna UsuiExecutive Director

Email: susui@calrheum.orgPhone: (310) 536-0460

Krystin Herr LarkinGovernment Affairs

Email: krystin@klgovaffairs.comPhone: (916) 502-2979

www.calrheum.org

SAVE THE DATECRA14th ANNUAL MEETING

May 5-6, 2018

Hotel Nikko San FranciscoSan Francisco, CA

SAVE THE DATECRA ADVOCACY SUMMIT

APRIL 2018

Sacramento, California

CORPORATE MEMBERSHIP FORMCalifornia Rheumatology Alliance | 2018

q

q

q

q

q

q

Sponsoring Company: Corporate Address: City: State: Zip: Country: Phone: Fax:

Please complete relevant contact information below:

My company would like to become:

Please list your company focus and product:

Agreement: I am an authorized representative for this company with full power and authority to sign this application. The company agrees to pay for sponsorship as noted on this form.

Authorized Signature: _________________________________ Date: __________________________

Please make checks payable and send to:

General Contact Information Government Relations/Advocacy Contact

Product/Brand Manager Contact

Name:Title:Address:City, State, Zip:Phone:Email:

Copy of me all correspondence related to CRA

Name:Title:Address:City, State, Zip:Phone:Email:

Copy of me all correspondence related to CRA

Name:Title:Address:City, State, Zip:Phone:Email:

Copy of me all correspondence related to CRA

California Rheumatology Alliance5230 Pacific Concourse Drive

Suite 100Los Angeles, CA 90045

CRA FIN # 33-1095347

q Gold $20,000 q Silver $10,000 q Bronze $5,000q Diamond $50,000 q Platinum $30,000